This federal contract award, valued at $17,940.00, was issued by the U.S. Department of Veterans Affairs (VA) to Pulmonx Corporation, a for-profit medical device manufacturer headquartered in Redwood City, California. The contract is for the delivery of endobronchial valves, which are used in minimally invasive lung volume reduction procedures to treat conditions such as emphysema and chronic obstructive pulmonary disease (COPD). This purchase order is a firm-fixed-price contract with a completion date of June 2, 2025, and it is not designated as a set-aside. Pulmonx Corporation's primary customers are various Veterans Integrated Service Networks (VISNs) within the VA, supporting the agency's mission to provide advanced healthcare services to veterans, particularly in the area of respiratory health and minimally invasive lung treatment technologies.
Generated 3/9/25, 1:00 AM